EMILY LITTMAN: Open Payments
NPI 1689223299 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 22 payments from 6 companies in 2025. Trend: 2023 $1,619 · 2024 $1,522 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $265 |
| GlaxoSmithKline, LLC. | 9 | $167 |
| Regeneron Healthcare Solutions, Inc. | 3 | $147 |
| United Therapeutics Corporation | 1 | $128 |
| Viatris Specialty LLC | 1 | $59 |
| Verona Pharma, Inc. | 1 | $33 |
Products named: DUPIXENT, FASENRA, NUCALA, TRELEGY ELLIPTA, YUPELRI, Ohtuvayre, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
